Letter: A Plot In Time

G. Christopher Anderson's story "Accelerator Planners Worry That SSC May Be A Hard Act To Follow" (The Scientist, Feb. 5, 1990, page 1), was very interesting. It triggered the thought: Do the early Rutherford experiments and the Cyclotron energy levels of the 1940s fit into his plot of log energy versus time? An "eagle eye" look at this plot indicates that the Bevatron fits onto his plot at about the right place. I realize that the intent of the plot relates to international competition for bi

Written byRalph Brodd
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

G. Christopher Anderson's story "Accelerator Planners Worry That SSC May Be A Hard Act To Follow" (The Scientist, Feb. 5, 1990, page 1), was very interesting. It triggered the thought: Do the early Rutherford experiments and the Cyclotron energy levels of the 1940s fit into his plot of log energy versus time? An "eagle eye" look at this plot indicates that the Bevatron fits onto his plot at about the right place.

I realize that the intent of the plot relates to international competition for bigger and better accelerators. Technology forecasting makes use of these plots to follow status of a given technology and to identify when a new technology will develop in order to continue progress. Perhaps there is also such a plot for the century to indicate progress.

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies